Scarica l'app Stockscreener
11.02
0.99%
-0.11
Precedente Chiudi:
$11.13
Aprire:
$11.185
Volume 24 ore:
7.33M
Relative Volume:
1.65
Capitalizzazione di mercato:
$5.45B
Reddito:
$4.45B
Utile/perdita netta:
$205.00M
Rapporto P/E:
27.55
EPS:
0.4
Flusso di cassa netto:
$372.00M
1 W Prestazione:
-2.04%
1M Prestazione:
-8.47%
6M Prestazione:
-25.84%
1 anno Prestazione:
-31.81%
Intervallo 1D:
$10.80
$11.50
Intervallo di 1 settimana:
$10.80
$11.50
Portata 52W:
$10.77
$18.80
Elanco Animal Health Inc Stock (ELAN) Company Profile
Nome
Elanco Animal Health Inc
Settore
Telefono
877-352-6261
Indirizzo
2500 INNOVATION WAY, GREENFIELD
Confronta ELAN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
11.02 | 5.45B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
160.46 | 71.85B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.08 | 45.58B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.58B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.74 | 19.18B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.60 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Elanco Animal Health Inc Stock (ELAN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Iniziato | UBS | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Market Perform |
| 2024-09-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | Aggiornamento | Stifel | Hold → Buy |
| 2023-12-19 | Iniziato | Jefferies | Buy |
| 2023-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-04-20 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2022-08-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Sell |
| 2022-07-12 | Iniziato | Piper Sandler | Neutral |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-10-28 | Downgrade | Stifel | Buy → Hold |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-06-15 | Aggiornamento | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-05-11 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2021-04-15 | Iniziato | Stifel | Buy |
| 2021-03-22 | Downgrade | Gabelli & Co | Buy → Hold |
| 2021-02-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | Downgrade | Argus | Buy → Hold |
| 2020-11-09 | Downgrade | Barclays | Overweight → Underweight |
| 2020-08-20 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | Ripresa | Credit Suisse | Neutral |
| 2020-08-04 | Ripresa | Goldman | Buy |
| 2020-07-27 | Downgrade | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | Iniziato | Raymond James | Mkt Perform |
| 2019-12-19 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | Iniziato | Barclays | Overweight |
| 2019-08-26 | Downgrade | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | Aggiornamento | UBS | Sell → Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-03-18 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | Ripresa | Morgan Stanley | Equal-Weight |
| 2019-02-12 | Iniziato | William Blair | Mkt Perform |
| 2019-01-23 | Iniziato | UBS | Sell |
| 2019-01-15 | Iniziato | Argus | Buy |
| 2018-10-15 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Elanco Animal Health Inc Borsa (ELAN) Ultime notizie
Officer Correia De Simas Jose Manuel covered exercise/tax liability with 11,808 shares and was granted 26,082 shares, increasing direct ownership by 29% to 64,042 units (SEC Form 4) - Quantisnow
Beyond The Numbers: 5 Analysts Discuss Elanco Animal Health Stock - Benzinga
Can Elanco's Leadership Reveal New Growth Strategies? Three Key Conferences to Watch - StockTitan
Elanco Animal Health (ELAN) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Investors who Lost Money on Elanco Animal Health Incorporated (ELAN) Should Contact Levi & Korsinsky about Pending Class ActionELAN - ACCESS Newswire
Tevra can amend antitrust complaint against Elanco, US judge says - MLex
ELAN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Elanco Animal Health Incorporated Stockholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Why Elanco Animal Health (ELAN) Is One of the Most Oversold Healthcare Stocks to Buy Now - Yahoo Finance
Elanco Launches Pet Protect Veterinarian-Formulated Supplements - Pet Age
Elanco debuts Pet Protect supplement line - Investing.com India
Can These New Vet-Backed Pet Supplements Transform Your Pet's Health? Advantage Makers Think So - StockTitan
Van ECK Associates Corp Raises Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Animal Health (NYSE:ELAN) Reaches New 52-Week LowTime to Sell? - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Stock Position Reduced by Davidson Investment Advisors - MarketBeat
ELANCO INVESTOR NOTIFICATION: BFA Law Encourages Elanco Investors that Incurred Losses to Contact the Firm about Securities Fraud Investigation - ACCESS Newswire
US FDA approves Elanco's treatment for parasitic infections in dogs - AOL
493,276 Shares in Elanco Animal Health Incorporated (NYSE:ELAN) Bought by DDD Partners LLC - MarketBeat
FINAL REMINDER ELAN DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Elanco Animal Health Incorporated Investors to Participate in the Class Action Lawsuit - ACCESS Newswire
Elanco Animal Health (NYSE:ELAN) Shares Down 6.4%Here's Why - MarketBeat
Breaking News - Today's Veterinary Business
ELAN INVESTOR NOTICE: Elanco is being Investigated for Securities Fraud; Investors with Losses are Encouraged to Contact BFA Law about a Potential Class Action - ACCESS Newswire
Poultry Vaccines Market Sales Statistics, Growth Outlook and Developments To 2032 | Elanco, Zoetis,Ceva, Phibro Corp.,MSD,Virbac, Hipra - The Globe and Mail
Elanco stock touches 52-week low at $11.11 amid market challenges - MSN
Equitable Trust Co. Acquires Shares of 125,807 Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Poultry Vaccine & Drug Market Booming as Demand for Disease Prevention Increases - GlobeNewswire Inc.
Elanco receives FDA warning letter over Zenrelia marketing (ELAN:NYSE) - Seeking Alpha
Shareholders that lost money on Elanco Animal Health Incorporated(ELAN) should contact Levi & Korsinsky about pending Class ActionELAN - ACCESS Newswire
Veterinary Oncology Market Detailed In New Research Report 2025 - openPR
Elanco Reinforces Commitment to Veterinary and Pet Owner Education - Nasdaq
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
Veterinary Medicine Market Growth, Demand, Industry Size & - openPR
Caprock Group LLC Trims Stock Holdings in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Elanco Looks Forward to Commercialization of Key Products in 2025 - Morningstar
(ELAN)Analyzing Elanco Animal Health's Short Interest - Benzinga
Elanco Animal Health Incorporated (ELAN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Veterinary Infectious Diseases Therapeutics Market Share - openPR
Private Management Group Inc. Grows Stock Position in Elanco Animal Health Incorporated (NYSE:ELAN) - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating Elanco Animal Health Incorporated (ELAN) And Encourages Investors to Connect - Markets Insider
Animal Doctor: Concerns about several veterinary drug products - Washington Times Herald
Bronstein, Gewirtz & Grossman, LLC Encourages Elanco Animal Health Incorporated (ELAN) Stockholders to Inquire about Securities Investigation - yourbigsky.com
Veterinary Eye Care Market to Grow by USD 1.05 Billion(2024-2028), Boosted by Rising Pet Ownership & Market Transformation Driven by AITechnavio - The Malaysian Reserve
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Elanco Animal Health Incorporated (ELAN) and Encourages Investors to Learn More About the Investigation - Markets Insider
Veterinary Wound Cleansers Market Share & Growth Forecast Report 2025-2030, with Elanco, Vetoquinol, Virbac, Innovacyn, Axio Biosolutions, Neogen, Pet Natural Remedies, Zoetis and More - Yahoo Finance
India’s Animal Healthcare Industry on a High-Growth Trajectory, Projected to Reach USD 2.0 Billion by 2034| Exclusive Report by Transparency Market Research Inc. - Yahoo Finance
Animal Parasiticides Market Witness Growth: Size, Share, - openPR
Elanco Launches Pradalex for Treatment of Livestock Respiratory Diseases - Drovers Magazine
BlackRock, Inc.'s Strategic Acquisition of Elanco Animal Health Inc Shares - GuruFocus.com
Elanco launches novel treatment for livestock respiratory diseases - Feedstuffs
Elanco Animal Health Inc Azioni (ELAN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.23%
3.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):